Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice

Author： Ahren B.   Holst J.J.   Martensson H.   Balkan B.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.404, Iss.1, 2000-09, pp. : 239-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-01 ,pp. : 1545-1552

Bentham Science Publishers

Access to resources Recommend Favorite

IV exenatide preserves glucose-dependent insulin secretion

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Novel N-substituted-2-cyanopyrrolidines as potent inhibitors of dipeptidyl peptidase IV in the treatment of non-insulin-dependent diabetes mellitus

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1937-1942

Informa Healthcare

Access to resources Recommend Favorite

Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?

By Michel Martin  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 377, Iss. 3, 2008-05 ,pp. : 205-207

Springer Publishing Company

Access to resources Recommend Favorite

Recent patents of dipeptidyl peptidase IV inhibitors

By Mendieta Laura   Tarrago Teresa   Giralt Ernest  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1693-1741

Informa Healthcare

Access to resources Recommend Favorite